BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9336461)

  • 1. The efficiency of a cis-cleaving ribozyme in an mRNA coding region is influenced by the translating ribosome in vivo.
    Zhang S; Stancek M; Isaksson LA
    Nucleic Acids Res; 1997 Nov; 25(21):4301-6. PubMed ID: 9336461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cis control of gene expression in E.coli by ribosome queuing at an inefficient translational stop signal.
    Jin H; Björnsson A; Isaksson LA
    EMBO J; 2002 Aug; 21(16):4357-67. PubMed ID: 12169638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual interactions between cleavage products of a cis-cleaving hammerhead ribozyme.
    Castanotto D; Chow WA; Li H; Rossi JJ
    Antisense Nucleic Acid Drug Dev; 1998 Dec; 8(6):499-506. PubMed ID: 9918114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between tumour necrosis factor alpha ribozyme and cellular proteins. Involvement in ribozyme stability and activity.
    Sioud M
    J Mol Biol; 1994 Oct; 242(5):619-29. PubMed ID: 7932719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of full-length beta APP mRNA by hammerhead ribozymes.
    Denman RB
    Nucleic Acids Res; 1993 Aug; 21(17):4119-25. PubMed ID: 8371986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient hammerhead ribozyme and antisense RNA targeting in a slow ribosome Escherichia coli mutant.
    Chen H; Ferbeyre G; Cedergren R
    Nat Biotechnol; 1997 May; 15(5):432-5. PubMed ID: 9131620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Only the last amino acids in the nascent peptide influence translation termination in Escherichia coli genes.
    Mottagui-Tabar S; Isaksson LA
    FEBS Lett; 1997 Sep; 414(1):165-70. PubMed ID: 9305752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A stable hammerhead structure is not required for endonucleolytic activity of a ribozyme in vivo.
    Steinecke P; Steger G; Schreier PH
    Gene; 1994 Nov; 149(1):47-54. PubMed ID: 7958987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Plasmodium falciparum ispH (lytB) gene expression by hammerhead ribozyme.
    Vinayak S; Sharma YD
    Oligonucleotides; 2007; 17(2):189-200. PubMed ID: 17638523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
    Phylactou LA; Tsipouras P; Kilpatrick MW
    Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cis-cleavage affects hammerhead and hairpin ribozyme steady-state levels differently and has strong impact on trans-targeting efficiency.
    Andäng M; Maijgren-Steffensson C; Hinkula J; Ahrlund-Richter L
    Oligonucleotides; 2004; 14(1):11-21. PubMed ID: 15104892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of a mRNA decay intermediate by ribosomal pausing at a stop codon.
    Björnsson A; Isaksson LA
    Nucleic Acids Res; 1996 May; 24(9):1753-7. PubMed ID: 8649996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural similarities between hammerhead ribozymes and the spliceosomal RNAs could be responsible for lack of ribozyme cleavage in yeast.
    Castanotto D; Li H; Chow W; Rossi JJ; Deshler JO
    Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):1-13. PubMed ID: 9512091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of hammerhead ribozyme-mediated cleavage and reduced expression of LacZ' mRNA in E. coli.
    Junn E; Kang C
    Genet Anal; 1996 May; 13(1):1-7. PubMed ID: 8781957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of the helix 2 region for the cis-cleaving and trans-cleaving activities of hepatitis delta virus ribozymes.
    Lee CB; Lai YC; Ping YH; Huang ZS; Lin JY; Wu HN
    Biochemistry; 1996 Sep; 35(38):12303-12. PubMed ID: 8823164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frameshifting at the internal stop codon within the mRNA for bacterial release factor-2 on eukaryotic ribosomes.
    Donly C; Williams J; Richardson C; Tate W
    Biochim Biophys Acta; 1990 Aug; 1050(1-3):283-7. PubMed ID: 2207158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein.
    Wiechen K; Zimmer C; Dietel M
    Cancer Gene Ther; 1998; 5(1):45-51. PubMed ID: 9476966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-cleaving-ribozyme-mediated reduction of betaAPP in human rhabdomyosarcoma cells.
    Dolzhanskaya N; Conti J; Schwenk V; Merz G; Denman RB
    Arch Biochem Biophys; 2001 Mar; 387(2):223-32. PubMed ID: 11370845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates.
    Sioud M
    Nucleic Acids Res; 1997 Jan; 25(2):333-8. PubMed ID: 9016562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis of chimeric anti-MDR1 ribozymes (tRNA-Rzs) and their biological activities in cell-free system].
    Wang F; Lei Z; Jin L
    Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):184-8. PubMed ID: 11778226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.